Cas:667414-42-8 3-[1-(2-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione manufacturer & supplier

We serve Chemical Name:3-[1-(2-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione CAS:667414-42-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-[1-(2-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione

Chemical Name:3-[1-(2-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione
CAS.NO:667414-42-8
Synonyms:3-[1-(2-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione
Molecular Formula:C14H17N3OS
Molecular Weight:275.36900
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:373ºC at 760 mmHg
Density:1.17g/cm3
Index of Refraction:1.601
PSA:78.74000
Exact Mass:275.10900
LogP:3.20120

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-[1-(2-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-[1-(2-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-[1-(2-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione Use and application,3-[1-(2-methylphenoxy)ethyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione technical grade,usp/ep/jp grade.


Related News: Besides McNamara’s hire, GSK said it’s expected to name a chair for the OTC firm later this year, who will then establish the board. 1-bromo-2-ethylnaphthalene manufacturers Along with Natural Biogenix were Symbiotec Pharmalab, Macleods Pharmaceutical, Optimus Drugs, Sudarshan Pharma, Saraca Laboratories, Emmennar Pharma, Hindys Lab, Aarti Speciality, Meghmani LLP and and Sadhana Nitro Chem. 3-butyl-3,4-dihydro-1H-benzo[d][1,2]oxazine suppliers Besides McNamara’s hire, GSK said it’s expected to name a chair for the OTC firm later this year, who will then establish the board. 2-{[4-(2-Butynyloxy)phenyl]sulfanyl}-N-hydroxy-2-(4-(2-thienyl)phenyl)-acetamide vendor & factory Aduhelm was approved by the Food and Drug Administration on June 7. The drug, scientifically known as aducanumab, offers new hope to friends and families of patients living with the disease and is expected to generate billions of dollars in revenue for the company.,Ireland is globally recognised as a hub for the Life Sciences sector and this news is a real vote of confidence in us and our capacity.”